Načítá se...
Patient subgroup identification for clinical drug development
Causal mechanism of relationship between the clinical outcome (efficacy or safety endpoints) and putative biomarkers, clinical baseline, and related predictors is usually unknown and must be deduced empirically from experimental data. Such relationships enable the development of tailored therapeutic...
Uloženo v:
| Vydáno v: | Stat Med |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7704099/ https://ncbi.nlm.nih.gov/pubmed/28147447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7236 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|